174 related articles for article (PubMed ID: 24161469)
1. In vitro and in vivo study of dolichyl phosphate on the efflux activity of P-glycoprotein at the blood-brain barrier.
Ji BS; Cen J; Liu L; He L
Int J Dev Neurosci; 2013 Dec; 31(8):828-35. PubMed ID: 24161469
[TBL] [Abstract][Full Text] [Related]
2. Effect of amyloid beta on ATP-binding cassette transporter expression and activity in porcine brain microvascular endothelial cells.
Shubbar MH; Penny JI
Biochim Biophys Acta Gen Subj; 2018 Oct; 1862(10):2314-2322. PubMed ID: 30048740
[TBL] [Abstract][Full Text] [Related]
3. Aβ40 Reduces P-Glycoprotein at the Blood-Brain Barrier through the Ubiquitin-Proteasome Pathway.
Hartz AM; Zhong Y; Wolf A; LeVine H; Miller DS; Bauer B
J Neurosci; 2016 Feb; 36(6):1930-41. PubMed ID: 26865616
[TBL] [Abstract][Full Text] [Related]
4. Setting-up an in vitro model of rat blood-brain barrier (BBB): a focus on BBB impermeability and receptor-mediated transport.
Molino Y; Jabès F; Lacassagne E; Gaudin N; Khrestchatisky M
J Vis Exp; 2014 Jun; (88):e51278. PubMed ID: 24998179
[TBL] [Abstract][Full Text] [Related]
5. Blood-Brain Barrier Disruption Increases Amyloid-Related Pathology in TgSwDI Mice.
Abdallah IM; Al-Shami KM; Yang E; Kaddoumi A
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33513818
[TBL] [Abstract][Full Text] [Related]
6. Effect of Phoneutria nigriventer venom on the expression of junctional protein and P-gp efflux pump function in the blood-brain barrier.
Rapôso C; Odorissi PA; Oliveira AL; Aoyama H; Ferreira CV; Verinaud L; Fontana K; Ruela-de-Sousa RR; da Cruz-Höfling MA
Neurochem Res; 2012 Sep; 37(9):1967-81. PubMed ID: 22684283
[TBL] [Abstract][Full Text] [Related]
7. The concerted amyloid-beta clearance of LRP1 and ABCB1/P-gp across the blood-brain barrier is linked by PICALM.
Storck SE; Hartz AMS; Bernard J; Wolf A; Kachlmeier A; Mahringer A; Weggen S; Pahnke J; Pietrzik CU
Brain Behav Immun; 2018 Oct; 73():21-33. PubMed ID: 30041013
[TBL] [Abstract][Full Text] [Related]
8. Borneol Depresses P-Glycoprotein Function by a NF-κB Signaling Mediated Mechanism in a Blood Brain Barrier in Vitro Model.
Fan X; Chai L; Zhang H; Wang Y; Zhang B; Gao X
Int J Mol Sci; 2015 Nov; 16(11):27576-88. PubMed ID: 26593909
[TBL] [Abstract][Full Text] [Related]
9. Abundance of P-Glycoprotein and Other Drug Transporters at the Human Blood-Brain Barrier in Alzheimer's Disease: A Quantitative Targeted Proteomic Study.
Storelli F; Billington S; Kumar AR; Unadkat JD
Clin Pharmacol Ther; 2021 Mar; 109(3):667-675. PubMed ID: 32885413
[TBL] [Abstract][Full Text] [Related]
10. HMGB1 promoted P-glycoprotein at the blood-brain barrier in MCAO rats via TLR4/NF-κB signaling pathway.
Wang F; Ji S; Wang M; Liu L; Li Q; Jiang F; Cen J; Ji B
Eur J Pharmacol; 2020 Aug; 880():173189. PubMed ID: 32417325
[TBL] [Abstract][Full Text] [Related]
11. Luteolin Inhibits Fibrillary β-Amyloid
Zhang JX; Xing JG; Wang LL; Jiang HL; Guo SL; Liu R
Molecules; 2017 Feb; 22(3):. PubMed ID: 28245546
[TBL] [Abstract][Full Text] [Related]
12. MDR1-P-Glycoprotein (ABCB1) Mediates Transport of Alzheimer's amyloid-beta peptides--implications for the mechanisms of Abeta clearance at the blood-brain barrier.
Kuhnke D; Jedlitschky G; Grube M; Krohn M; Jucker M; Mosyagin I; Cascorbi I; Walker LC; Kroemer HK; Warzok RW; Vogelgesang S
Brain Pathol; 2007 Oct; 17(4):347-53. PubMed ID: 17610523
[TBL] [Abstract][Full Text] [Related]
13. P-glycoprotein mediated efflux limits the transport of the novel anti-Parkinson's disease candidate drug FLZ across the physiological and PD pathological in vitro BBB models.
Liu Q; Hou J; Chen X; Liu G; Zhang D; Sun H; Zhang J
PLoS One; 2014; 9(7):e102442. PubMed ID: 25036090
[TBL] [Abstract][Full Text] [Related]
14. P-glycoprotein in blood-brain barrier endothelial cells: interaction and oligomerization with caveolins.
Jodoin J; Demeule M; Fenart L; Cecchelli R; Farmer S; Linton KJ; Higgins CF; Béliveau R
J Neurochem; 2003 Nov; 87(4):1010-23. PubMed ID: 14622130
[TBL] [Abstract][Full Text] [Related]
15. New Evidence for P-gp-Mediated Export of Amyloid-β PEPTIDES in Molecular, Blood-Brain Barrier and Neuronal Models.
Chai AB; Hartz AMS; Gao X; Yang A; Callaghan R; Gelissen IC
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33383667
[TBL] [Abstract][Full Text] [Related]
16. Glutamate up-regulates P-glycoprotein expression in rat brain microvessel endothelial cells by an NMDA receptor-mediated mechanism.
Zhu HJ; Liu GQ
Life Sci; 2004 Jul; 75(11):1313-22. PubMed ID: 15234189
[TBL] [Abstract][Full Text] [Related]
17. Increase in P-glycoprotein levels in the blood-brain barrier of partial portal vein ligation /chronic hyperammonemia rats is medicated by ammonia/reactive oxygen species/ERK1/2 activation: In vitro and in vivo studies.
Zhou Y; Zhou J; Li P; Xie Q; Sun B; Li Y; Chen Y; Zhao K; Yang T; Zhu L; Xu J; Liu X; Liu L
Eur J Pharmacol; 2019 Mar; 846():119-127. PubMed ID: 30639310
[TBL] [Abstract][Full Text] [Related]
18. A functional in vitro model of rat blood-brain barrier for molecular analysis of efflux transporters.
Perrière N; Yousif S; Cazaubon S; Chaverot N; Bourasset F; Cisternino S; Declèves X; Hori S; Terasaki T; Deli M; Scherrmann JM; Temsamani J; Roux F; Couraud PO
Brain Res; 2007 May; 1150():1-13. PubMed ID: 17434463
[TBL] [Abstract][Full Text] [Related]
19. Modulation of P-glycoprotein in rat brain microvessel endothelial cells under oxygen glucose deprivation.
Ji BS; Cen J; He L; Liu M; Liu YQ; Liu L
J Pharm Pharmacol; 2013 Oct; 65(10):1508-17. PubMed ID: 24028618
[TBL] [Abstract][Full Text] [Related]
20. Modelling the endothelial blood-CNS barriers: a method for the production of robust in vitro models of the rat blood-brain barrier and blood-spinal cord barrier.
Watson PM; Paterson JC; Thom G; Ginman U; Lundquist S; Webster CI
BMC Neurosci; 2013 Jun; 14():59. PubMed ID: 23773766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
